We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current COEP market cap is 26.56M. The company's latest EPS is USD -3.0955 and P/E is -3.86.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.63M | -2.92M | -2.83M | -2.14M | -2.17M |
| Net Income | -4.03M | -3M | -3.04M | -1.83M | -3.01M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -68k | -681k | -34.2M | -21.49M | -10.06M |
| Net Income | -67k | 15.23M | -37.57M | -21.27M | -10.88M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.07M | 9.39M | 4.2M | 8.96M | 8.91M |
| Total Liabilities | 3.76M | 5.04M | 4.51M | 3.97M | 5.04M |
| Total Equity | 4.31M | 4.36M | -310k | 4.98M | 3.87M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 76.71M | 76.17M | 7.92M | 8.07M | 8.91M |
| Total Liabilities | 2.26M | 7.19M | 3.11M | 3.76M | 5.04M |
| Total Equity | 5M | -6.77M | 4.8M | 4.31M | 3.87M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.24M | -1.9M | -3.32M | -5.21M | -6.65M |
| Investing | N/A | -100k | -100k | -100k | N/A |
| Financing | 4.92M | 1.56M | 3.51M | 4.98M | 5.71M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -116k | -503k | -3.88M | -7.24M | -6.65M |
| Investing | -75.75M | N/A | N/A | N/A | N/A |
| Financing | 76.77M | N/A | 5.49M | 4.92M | 5.71M |
| Market Cap | 26.56M |
| Price to Earnings Ratio | -3.86 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 78.77 |
| Price to Book Ratio | 10.86 |
| Dividend Yield | - |
| Shares Outstanding | 3.51M |
| Average Volume (1 week) | 17.83k |
| Average Volume (1 Month) | 24.88k |
| 52 Week Change | 19.24% |
| 52 Week High | 15.51 |
| 52 Week Low | 2.31 |
| Spread (Intraday) | 43.09 (86.18%) |
| Company Name | Coeptis Therapeutics Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.coeptistx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
